[Anti-androgenic therapy for prostate carcinoma].
D000135:Acid Phosphatase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D000726:Androgen Antagonists; D000818:Animals; D002369:Castration; D002712:Chlorides / Q000032:analysis; D003534:Cyproterone / Q000494:pharmacology / Q000627:therapeutic use; D003864:Depression, Chemical; D004054:Diethylstilbestrol / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D005947:Glucose / Q000032:analysis; D008297:Male; D009994:Osmolar Concentration; D011188:Potassium / Q000032:analysis; D011245:Pregnadienes / Q000494:pharmacology*; D011467:Prostate / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011506:Proteins / Q000032:analysis; D012636:Secretory Rate / Q000187:drug effects; D012964:Sodium / Q000032:analysis; D013739:Testosterone / Q000494:pharmacology
D000726:Androgen Antagonists; D002712:Chlorides; D011245:Pregnadienes; D011506:Proteins; D013739:Testosterone; D004054:Diethylstilbestrol; D012964:Sodium; D003534:Cyproterone; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D005947:Glucose; D011188:Potassium
Anti-androgeenterapie vir Prostaatkarsinoom.